Shares outstanding decreased 96.6%
Shares outstanding changed -96.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
20,216,176→694,8268 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NVNO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 27.6%
Operating cash flow changed +27.6% from the comparable as-filed period.
-$4.4M→-$3.2M2 prior comparisons
Cash & equivalents increased 67.4%
Cash & equivalents changed +67.4% from the comparable as-filed period.
$1.5M→$2.6M3 prior comparisons
Current assets decreased 39.6%
Current assets changed -39.6% from the comparable as-filed period.
$31.5M→$19.0M3 prior comparisons
Working capital decreased 43.5%
Working capital changed -43.5% from the comparable as-filed period.
$29.1M→$16.4M3 prior comparisons
Total assets decreased 39.8%
Total assets changed -39.8% from the comparable as-filed period.
$32.4M→$19.5M3 prior comparisons
Stock-based compensation decreased 40.4%
Stock-based compensation changed -40.4% from the comparable as-filed period.
$688,000→$410,0002 prior comparisons
Current ratio decreased 44.0%
Current ratio changed -44.0% from the comparable as-filed period.
13.12→7.353 prior comparisons
Selling, general & administrative decreased 27.9%
Selling, general & administrative changed -27.9% from the comparable as-filed period.
$2.3M→$1.7M2 prior comparisons
Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period.
$9,000→$03 prior comparisons
Working capital / assets moved 564 bp lower
Working capital / assets changed -564 basis points from the comparable as-filed period.
89.94%→84.31%3 prior comparisons
Operating income increased 7.1%
Operating income changed +7.1% from the comparable as-filed period.
-$4.9M→-$4.5M2 prior comparisons
Research & development increased 11.3%
Research & development changed +11.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.6M→$2.9M2 prior comparisons
Net income increased 3.8%
Net income changed +3.8% from the comparable as-filed period.
-$4.5M→-$4.4M2 prior comparisons
Current liabilities increased 7.9%
Current liabilities changed +7.9% from the comparable as-filed period.
$2.4M→$2.6M3 prior comparisons
Shares outstanding decreased 96.5%
Shares outstanding changed -96.5% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
19,247,141→682,7228 prior comparisons
Operating income increased 46.1%
Operating income changed +46.1% from the comparable as-filed period.
-$7.0M→-$3.8M2 prior comparisons
Net income increased 46.2%
Net income changed +46.2% from the comparable as-filed period.
-$6.7M→-$3.6M2 prior comparisons
Current liabilities decreased 37.4%
Current liabilities changed -37.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$3.0M→$1.9M3 prior comparisons
Research & development decreased 28.2%
Research & development changed -28.2% from the comparable as-filed period.
$2.9M→$2.1M2 prior comparisons
Selling, general & administrative decreased 58.6%
Selling, general & administrative changed -58.6% from the comparable as-filed period.
$4.2M→$1.7M2 prior comparisons
Working capital decreased 38.0%
Working capital changed -38.0% from the comparable as-filed period.
$32.6M→$20.2M3 prior comparisons
Total assets decreased 38.0%
Total assets changed -38.0% from the comparable as-filed period.
$36.6M→$22.7M3 prior comparisons
Stock-based compensation decreased 72.5%
Stock-based compensation changed -72.5% from the comparable as-filed period.
$1.4M→$397,0003 prior comparisons
Current assets decreased 38.0%
Current assets changed -38.0% from the comparable as-filed period.
$35.6M→$22.1M3 prior comparisons
Cash & equivalents increased 39.0%
Cash & equivalents changed +39.0% from the comparable as-filed period.
$2.0M→$2.8M3 prior comparisons
Operating cash flow increased 4.5%
Operating cash flow changed +4.5% from the comparable as-filed period.
-$3.7M→-$3.5M3 prior comparisons
Working capital / assets moved 2 bp higher
Working capital / assets changed +2 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
89.10%→89.12%3 prior comparisons
Current ratio decreased 0.9%
Current ratio changed -0.9% from the comparable as-filed period.
11.81→11.73 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.